Switch to: References

Add citations

You must login to add citations.
  1. Patients' health or company profits? The commercialisation of academic research.Nancy F. Olivieri - 2003 - Science and Engineering Ethics 9 (1):29-41.
    This paper is a personal account of the events associated with the author’s work at the University of Toronto’s Hospital for Sick Children on a drug, deferiprone, for the treatment of thalassaemia. Trials of the drug were sponsored by the Canadian Medical Research Council and a drug company which would have been able, had the trials been successful, to seek regulatory approval to market the drug. When evidence emerged that deferiprone might be inadequately effective in a substantial proportion of patients, (...)
    Download  
     
    Export citation  
     
    Bookmark   12 citations